Define the decision your documents need to support.
A peptide certificate of analysis is useful when it can be connected to the material you intend to receive. Before reviewing a percentage or a laboratory logo, record the full material identity, required quantity, per-unit content, intended research specification and proposed batch reference.
This guide is a procurement checklist. It does not validate a particular supplier, replace your laboratory’s technical review or provide a universal release specification. The tests and acceptance criteria needed for a project should be agreed before an order is accepted.
Material
Product name, relevant sequence or identifier, chemical form and any specified modifications.
Order
Quantity, pack configuration, stated content and destination warehouse.
Batch
Proposed lot, sample reference and the reports that apply to that material.
Decision
Required methods, acceptance criteria and the person responsible for technical review.
1. Follow the batch reference through every record.
Compare the quotation, COA, supporting test reports and proposed product label. If different identifiers are used, ask for a written explanation connecting them. A report for another lot, or a document with no clear sample reference, needs clarification before it can support the proposed purchase.
| Record | What to match | Question to resolve |
|---|---|---|
| Quotation or specification | Material identity, quantity, content and proposed lot | Does the document describe the exact supply being offered? |
| COA | Product, batch, report reference, dates, methods and results | Is this the current report for the proposed batch? |
| Supporting analysis | Sample ID, test method and link to the COA | Which sample was tested and how does it relate to the supplied lot? |
| Label and receiving record | Material, lot and agreed pack identifiers | Will your receiving team be able to reconcile the delivery with the approved records? |
For a repacked or private-label product, agree how the original material lot and your branded lot will be connected. Retain that mapping with the order documentation rather than relying on a product name alone.
2. Separate identity, chromatographic purity and content.
Different measurements answer different questions. In its archived peptide reference-material report, NIST describes UV chromatographic area percentage separately from peptide mass purity. That distinction is a useful reminder to ask what a reported “purity” figure actually measures. The archived report is a methodological example, not a current certificate for a product on this website. NIST RM 8327 report, pages 1 and 4 (PDF).
| Result | Useful review question | Avoid assuming |
|---|---|---|
| HPLC / UPLC area purity | Which method, detector conditions and integration rules produced the reported area percentage? | That an area percentage establishes the amount of peptide in each vial. |
| Mass spectrometry | What mass was observed, what identity was expected and what interpretation does the laboratory provide? | That an expected mass alone verifies the complete sequence or every possible impurity. |
| Content or assay | What quantity was measured, in which units, using which basis and method? | That total powder weight, stated vial content and measured peptide content are interchangeable. |
LC/MS can determine peptide mass, while MS/MS analysis can add sequence evidence through fragmentation. The method and interpretation matter: ask your technical reviewer whether the evidence is sufficient for the material. Agilent’s peptide characterisation reference.
Where measured content is important, specify it separately from chromatographic purity in your enquiry. NIST’s research on peptide purity value assignment compares approaches including mass balance and amino acid analysis, illustrating why the measured quantity and method should be explicit. NIST publication on peptide purity measurement.
3. Review the actual report, including its status.
Request legible documents with enough context for your laboratory to review the findings. Identify the issuing organisation, report reference, sample, test date, method, units, results and any stated qualifications. Ask whether the report is final, preliminary or amended, and retain the current version.
NATA explains that accredited reports describe the activities performed and their results; preliminary status, subcontracted results and amendments need appropriate identification. Use those distinctions as questions when reviewing the documents supplied for your order. NATA: test reports explained.
If a method name or summary result is insufficient for your project, state the supporting data you need in the quotation stage. This may include a chromatogram, spectrum or more detailed method information where available. Confirm availability and any additional work before agreeing to supply.
4. Check the credential and the relevant testing scope.
If accredited testing is required, record the laboratory’s legal name, accreditation body and reference, current status, and the methods within its published scope. Confirm whether the particular result is covered rather than treating a general laboratory credential as proof for every test.
NATA’s ISO/IEC 17025 guidance ties laboratory competence to the methods and procedures in the accreditation scope. Its organisation directory lets buyers review listed facilities and scopes. NATA accreditation guidance · NATA organisation directory.
The references in this guide are educational sources, not named testing partners or endorsements of Wholesale Lab Peptides. Specific laboratory credentials and batch records must be confirmed for the proposed order. For market-specific documentation questions, see certificates and laboratory testing.
5. Turn missing information into written questions.
- Unmatched batch. Ask how the test sample and report connect to the lot being offered.
- Unclear purity figure. Ask which quantity, method and reporting basis produced the result.
- Content requirement. State the measured content or assay evidence your project needs rather than assuming it from a label.
- Additional tests. List any required analyses separately and ask whether corresponding results exist for the batch.
- Storage or retest information. Ask for the product-specific conditions and the basis of any date supplied.
- Private-label supply. Agree the material-to-branded-lot mapping and who retains the original reports.
A report answers only the questions addressed by its methods and scope. Additional attributes require their own relevant evidence. This guide does not establish sterility, clinical safety or approval for administration.
6. Carry the approved documents through receiving and reorder.
Before dispatch, keep the accepted specification, final quote, agreed batch references and relevant reports together. On receipt, reconcile the product and lot identifiers with those records and follow the supplied handling information.
For a repeat order, ask whether the material or batch has changed and review the documents applicable to the new supply. For an agreed split shipment, record which lots belong to each release. Do not assume that approval of an earlier batch covers every later delivery.
If a delivery does not match the agreed records, retain the relevant documents and contact our team with the order and batch references. Read our receiving and dispatch information and order-concern policy.
Send a document brief with your quotation request.
Include your organisation, full material identity, quantity and destination, then list the required tests, acceptance criteria and accreditation scope. Tell us which records must be reviewed before you can approve the order.
Prepare a batch-document requestOr email sales@wholesalelabpeptides.com. Our wholesale catalogue enquiry page and OEM project guide explain the other details to include.